GlassScriptPhysician profile
William G Imlach
NPI 1699850610
$5,440.91
in general payments reported to CMS, 2019-2025
32 companies · $1,315 in 2025
The $1,315 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $338 · 2021: $311 · 2022: $866 · 2023: $820 · 2024: $975 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,066 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,065.76 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,681.94 | 2021-2025 | |
| Lilly USA, LLC | $696.21 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $511.74 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $403.71 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $370.61 | 2019-2023 | Spiriva Respimat, Jardiance |
| Glaxosmithkline, LLC. | $241.53 | 2019-2024 | Shingrix, Arexvy |
| Allergan, INC. | $190.64 | 2019-2020 | |
| Exact Sciences Corporation | $123.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $103.73 | 2019-2024 | Breztri, Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $96.72 | 2024-2025 | |
| Radius Health, INC. | $96.39 | 2024-2025 | Tymlos |
| Dexcom, INC. | $96.22 | 2023-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $82.68 | 2023-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $81.43 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $77.91 | 2022-2025 | Spravato |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $70.17 | 2025 | Apretude |
| Astellas Pharma US INC | $60.99 | 2019-2025 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $56.08 | 2022-2025 | Eliquis |
| Sumitomo Pharma America, INC. | $52.07 | 2025 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $47.46 | 2020 | |
| Horizon Therapeutics Plc | $44.34 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $40.23 | 2022-2024 | Gardasil, Gardasil 9, Capvaxive |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $34.76 | 2024-2025 | Caplyta |
| Ardelyx, INC. | $27.13 | 2025 | Ibsrela |
| Aimmune Therapeutics, INC. | $25.62 | 2025 | Zenpep |
| Advanced Respiratory, INC | $23.70 | 2019 | |
| Sobi, INC | $19.19 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.13 | 2019 | |
| Eisai INC. | $18.36 | 2025 | |
| Amarin Pharma, INC. | $17.01 | 2020 | |
| Celgene Corporation | $15.13 | 2025 | Reblozyl |
| Antares Pharma, INC. | $14.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Imlach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.